Efatutazone
- Generic Name
- Efatutazone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H26N4O4S
- CAS Number
- 223132-37-4
- Unique Ingredient Identifier
- M17ILL71MC
- Background
Efatutazone has been used in trials studying the treatment of Lymphoma, Liposarcoma, Solid Tumors, Multiple Myeloma, and Recurrent Thyroid Cancer, among others.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath